How High Will OXY Stock Go Now?
Occidental Petroleum (NYSE:OXY), a stock that has been made famous…
Sell
28
RAMP Quote, Financials, Valuation and Earnings
Last price:
$30.11
Seasonality move
:
3.67%
Day range:
$29.80 - $31.53
52-week range:
$21.45 - $36.08
Dividend yield:
0%
P/E ratio:
2,807.00x
P/S ratio:
2.69x
P/B ratio:
2.06x
Volume:
703.6K
Avg. volume:
587.8K
1-year change:
3.33%
Market cap:
$2B
Revenue:
$745.6M
EPS (TTM):
-$0.01
Analysts' Opinion
-
Consensus RatingLiveRamp Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $38.71, LiveRamp Holdings has an estimated upside of 28.53% from its current price of $30.12.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $28.00 representing 100% downside risk from its current price of $30.12.
Fair Value
-
According to the consensus of 7 analysts, LiveRamp Holdings has 28.53% upside to fair value with a price target of $38.71 per share.
RAMP vs. S&P 500
-
Over the past 5 trading days, LiveRamp Holdings has underperformed the S&P 500 by -8.68% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
LiveRamp Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
LiveRamp Holdings has grown year-over-year revenues for 27 quarters straight. In the most recent quarter LiveRamp Holdings reported revenues of $188.7M.
Earnings Growth
-
LiveRamp Holdings earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter LiveRamp Holdings reported earnings per share of -$0.10.
Enterprise value:
1.5B
EV / Invested capital:
1.62x
Price / LTM sales:
2.69x
EV / EBIT:
66.79x
EV / Revenue:
2.06x
PEG ratio (5yr expected):
--
EV / Free cash flow:
9.94x
Price / Operating cash flow:
12.99x
Enterprise value / EBITDA:
38.21x
Gross Profit (TTM):
$529.7M
Return On Assets:
-0.07%
Net Income Margin (TTM):
-0.11%
Return On Equity:
-0.09%
Return On Invested Capital:
-0.09%
Operating Margin:
-2.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $596.6M | $659.7M | $745.6M | $171.9M | $188.7M | |
| Gross Profit | $426.5M | $480.2M | $529.7M | $124.1M | $130.8M | |
| Operating Income | -$90.5M | $23.1M | $13.4M | -$11.8M | -$4.3M | |
| EBITDA | -$97.7M | $46.3M | $40.2M | $3.7M | $9.1M | |
| Diluted EPS | -$1.79 | $0.18 | -$0.01 | -$0.08 | -$0.10 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $825.7M | $815.8M | $714.6M | $602M | $656.2M | |
| Total Assets | $1.3B | $1.3B | $1.2B | $1.2B | $1.3B | |
| Current Liabilities | $165.2M | $184.6M | $174.8M | $216.6M | $247.5M | |
| Total Liabilities | $207.6M | $270.7M | $246.6M | $282.3M | $310.5M | |
| Total Equity | $1.1B | $1.1B | $926.1M | $949.1M | $948.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $39.8M | $107.4M | $155.7M | $28.4M | $61.8M | |
| Cash From Investing | -$29M | -$173.7M | $21.4M | -$171.6M | $470K | |
| Cash From Financing | -$146M | -$59.1M | -$102.7M | -$15.9M | -$26.3M | |
| Free Cash Flow | $35.1M | $103.2M | $154.6M | $26.7M | $61.5M | |
RAMP
Sector
Market Cap
$2B
$83.1M
Price % of 52-Week High
83.48%
62.94%
Dividend Yield
0%
0%
Shareholder Yield
5.92%
0.81%
1-Year Price Total Return
3.33%
-11.11%
Beta (5-Year)
1.014
0.823
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$32.07
200-day SMA
Buy
Level
$28.63
Bollinger Bands (100)
Buy
Level
26.15 - 32.91
Chaikin Money Flow
Buy
Level
134.6M
20-day SMA
Sell
Level
$32.17
Relative Strength Index (RSI14)
Sell
Level
43.70
ADX Line
Sell
Level
32.32
Williams %R
Buy
Level
-91.7949
50-day SMA
Buy
Level
$28.97
MACD (12, 26)
Buy
Level
0.60
25-day Aroon Oscillator
Buy
Level
4
On Balance Volume
Neutral
Level
59.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.8059)
Buy
CA Score
(Annual)
Level (1.0559)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-9.7579)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.
Stock Forecast FAQ
In the current month, RAMP has received 4 Buy ratings 3 Hold ratings, and 0 Sell ratings. The RAMP average analyst price target in the past 3 months is $38.71.
-
Where Will LiveRamp Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that LiveRamp Holdings share price will rise to $38.71 per share over the next 12 months.
-
What Do Analysts Say About LiveRamp Holdings?
Analysts are divided on their view about LiveRamp Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that LiveRamp Holdings is a Sell and believe this share price will drop from its current level to $28.00.
-
What Is LiveRamp Holdings's Price Target?
The price target for LiveRamp Holdings over the next 1-year time period is forecast to be $38.71 according to 7 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is RAMP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for LiveRamp Holdings is a Buy. 4 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of RAMP?
You can purchase shares of LiveRamp Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase LiveRamp Holdings shares.
-
What Is The LiveRamp Holdings Share Price Today?
LiveRamp Holdings was last trading at $30.11 per share. This represents the most recent stock quote for LiveRamp Holdings. Yesterday, LiveRamp Holdings closed at $30.12 per share.
-
How To Buy LiveRamp Holdings Stock Online?
In order to purchase LiveRamp Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Stellantis a Good Dividend Stock to Buy Right Now?
Stellantis (NYSE: STLA) isn’t the first name most income investors think of,…
Where Will Brookfield Asset Management Stock Be In 1 Year?
On a trailing basis Brookfield earned $1.60 per share over…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
83
ARQQ alert for Jun 19
Arqit Quantum [ARQQ] is up 22.6% over the past day.
Sell
47
RGC alert for Jun 19
Regencell Bioscience Holdings [RGC] is down 18.36% over the past day.
Sell
49
QNTM alert for Jun 19
Quantum BioPharma [QNTM] is up 17.61% over the past day.
